# Evaluation of Neurologic and Psychiatric Adverse Events of Several Antiretroviral Drugs in Real Life Setting

> **NCT02882230** · — · TERMINATED · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 1 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** prescription of at least one of the following drugs: rilpivirine, elvitegravir, dolutegravir

## Key facts

- **NCT ID:** NCT02882230
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-19
- **Primary completion:** 2018-12-03
- **Final completion:** 2019-01-15
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Unfavourable opinion of ethical comittee for Amendment Nr 3
- **Last updated:** 2020-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02882230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02882230, "Evaluation of Neurologic and Psychiatric Adverse Events of Several Antiretroviral Drugs in Real Life Setting". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02882230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*